Detalhe da pesquisa
1.
Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery.
Gene Ther
; 31(3-4): 74-84, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37558852
2.
Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus.
J Gen Virol
; 103(6)2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35671066
3.
The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.
Genome Biol
; 21(1): 195, 2020 08 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32762776